Virtus ETF Advisers’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,172
Closed -$221K 410
2018
Q3
$221K Sell
11,172
-8,201
-42% -$162K 0.02% 190
2018
Q2
$615K Buy
19,373
+9,567
+98% +$304K 0.54% 130
2018
Q1
$363K Buy
9,806
+5,395
+122% +$200K 0.32% 114
2017
Q4
$348K Buy
+4,411
New +$348K 0.44% 95